Thursday, 23 February 2012

PPMD Announces Board Approved FDA Policy - PPMD Community

PPMD Announces Board Approved FDA Policy - PPMD Community: "At this time, Congress is working on writing a critical FDA related bill called the Prescription Drug User Fee Act (PDUFA), and PPMD is working with other rare disease advocates on provisions to benefit our sons. Earlier this year, the PPMD Board of Directors adopted a policy position that, among other things, seeks to ensure the potential benefits of a therapy are weighted appropriately against possible risks.

PPMD is working now to develop a specific legislative provision or provisions that would advance these core principles, and will be committed to working this issue as Congress writes its FDA bill over the coming months.

Please take a moment to read this policy. We cannot stress enough how important it is for your family, for every Duchenne family and organization to understand this topic, as it will most definitely impact how quickly treatments are available to our sons."

'via Blog this'

No comments:

Post a Comment